These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27662377)

  • 1. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
    Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
    Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
    Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
    Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
    Li J; Chen L; Zhang X; Zhang Y; Liu H; Sun B; Zhao L; Ge N; Qian H; Yang Y; Wu M; Yin Z
    PLoS One; 2014; 9(4):e96185. PubMed ID: 24763545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
    Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
    BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
    Xu W; Cao L; Chen L; Li J; Zhang XF; Qian HH; Kang XY; Zhang Y; Liao J; Shi LH; Yang YF; Wu MC; Yin ZF
    Clin Cancer Res; 2011 Jun; 17(11):3783-93. PubMed ID: 21527564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
    Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
    Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
    Wu C; Li P; Fan N; Han J; Zhang W; Zhang W; Tang B
    ACS Appl Mater Interfaces; 2019 Dec; 11(48):44999-45006. PubMed ID: 31714050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells.
    Chen L; Wu LL; Zhang ZL; Hu J; Tang M; Qi CB; Li N; Pang DW
    Biosens Bioelectron; 2016 Nov; 85():633-640. PubMed ID: 27240010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Isolation and Phenotypic Profiling of Circulating Hepatocellular Carcinoma Cells via a Combinatorial-Antibody-Functionalized Microfluidic Synergetic-Chip.
    Zhu L; Lin H; Wan S; Chen X; Wu L; Zhu Z; Song Y; Hu B; Yang C
    Anal Chem; 2020 Nov; 92(22):15229-15235. PubMed ID: 33124804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis.
    Zhang Y; Shi ZL; Yang X; Yin ZF
    World J Gastroenterol; 2014 Jan; 20(1):142-7. PubMed ID: 24415867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
    Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives.
    Zhang Y; Li J; Cao L; Xu W; Yin Z
    Semin Oncol; 2012 Aug; 39(4):449-60. PubMed ID: 22846862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.